Target intelligence / Profile preview

Neuronal vesicle trafficking-associated protein 2 (NSG2)

Target
NSG2
Molecular classification
Other
01

Overview

Neuronal vesicle trafficking-associated protein 2 (NSG2) is a small type II transmembrane protein predominantly expressed in neurons, especially in the brain and Golgi apparatus. NSG2 is endocytosed from the neuronal cell surface, traffics through early and late endosomes, and is then rapidly degraded in lysosomes with a half-life under two hours. It partially co-localizes with neuronal endosomal markers and has been implicated in regulating membrane trafficking, including the postsynaptic distribution of neurotransmitter receptors. NSG2 is predicted to bind clathrin light chains and participate in clathrin coat assembly and endosomal transport. The gene is genetically linked to rare forms of ataxia but is currently not directly implicated in common neurodegenerative or neuropsychiatric conditions. NSG2 is poorly studied and not considered a classical drug target such as a receptor or transporter; its function appears to involve neuronal membrane protein homeostasis and degradative trafficking, rather than serving as a signaling receiver or enzyme.

Other names
NSG2CALY3Hmp19HMP19Neuron-specific protein family member 2Protein p19calcyon family member 3hypothalamus Golgi apparatus expressed 19 kDa proteinp19 protein
02

Biological functions

Endosomal transportClathrin coat assemblyRegulation of postsynaptic membrane neurotransmitter receptor levelsRapid trafficking and degradation
03

Disease associations

Spinocerebellar Ataxia 18 (genetic association)Episodic Ataxia, Type 6 (genetic association)No direct, mechanistically confirmed roles in other diseases

Beyond the preview

Go deeper on Neuronal vesicle trafficking-associated protein 2 (NSG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal vesicle trafficking-associated protein 2 (NSG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call